BioSpace News Archive

Canadian public health guidance related to COVID-19 has been changing as the evidence base and our understanding of COVID-19 is rapidly evolving.

The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic

Willow Biosciences Inc. (“Willow” or “the Company”) (TSX: WLLW; OTCQB: CANSF) announces changes to its management team with the promotion of Dr. Chris Savile to Chief Operations Officer and the departure of Dr. Peter Facchini, Chief Scientific Officer, and Dr. Jill Hagel, Vice President, Applied Science, effective immediately.

Zelira Therapeutics Ltd (ASX: ZLD, OTCQB: ZLDAF), a global leader in the development of clinically validated cannabis medicines based in both Perth, Australia and Philadelphia, is pleased to announce it has received the final report for its ZTL-101 medicinal cannabis trial for insomnia.

Serological tests measure the amount of antibodies or proteins present in the blood when the body is responding to a specific infection, like COVID-19.

Cryosauna manufacturer pivots production to manufacture oxygen hoses for hospital staff in New York City—and around the country— who are desperate to save the lives of individuals battling COVID-19.

ETHOS Health Communications, a Pennsylvania-based medical communications agency specializing in interpreting and communicating the innovative science and data for cutting-edge therapies, announced its name change to PRECISIONscientia

Aveanna Healthcare (“Aveanna”), a leading home healthcare company, today announced the launch of its new remote healthcare platform, Aveanna Teletherapy.

Baylis Medical, a Canadian-based medical device company specializing in cardiology and spine, announced that it is partnering with Ventilators for Canadians, a consortium of Canadian manufacturers, to manufacture ventilators for hospitals across Canada.

Growing awareness amongst the public and government is creating scope for vaccination of other diseases such as Hepatitis B. According to the PMR report, public awareness will play a vital role in the surge of hepatitis B vaccinations.